Literature DB >> 8192475

Penetration of vancomycin into mediastinal and cardiac tissues in humans.

C Martin1, M Alaya, M N Mallet, X Viviand, K Ennabli, R Said, P De Micco.   

Abstract

Vancomycin penetration into heart tissues (valves, myocardium, auricles, and pericardium) and mediastinal tissues (fat and sternal bone) was evaluated after two regimens of vancomycin administration. Ten patients were given 15 mg of vancomycin per kg of body weight before anesthesia. Ten other patients received the same dose and then a second 7.5-mg/kg dose at the time of initiation of cardiopulmonary bypass. Similar and satisfactory vancomycin tissue penetrations were observed in both groups. However, for some patients in the two groups, vancomycin levels in tissue were less than the MICs for potential pathogens (Staphylococcus aureus and Staphylococcus epidermidis).

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8192475      PMCID: PMC284467          DOI: 10.1128/AAC.38.2.396

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  18 in total

1.  Penetration of vancomycin in uninfected sternal bone.

Authors:  L Massias; C Dubois; P de Lentdecker; O Brodaty; M Fischler; R Farinotti
Journal:  Antimicrob Agents Chemother       Date:  1992-11       Impact factor: 5.191

2.  Determination of bone and fat concentrations following systemic cefamandole and regional cefuroxime administration in patients undergoing knee arthroplasty.

Authors:  C Hoddinott; A M Lovering; H C Fernando; J H Dixon; D S Reeves
Journal:  J Antimicrob Chemother       Date:  1990-12       Impact factor: 5.790

3.  The effective period of preventive antibiotic action in experimental incisions and dermal lesions.

Authors:  J F Burke
Journal:  Surgery       Date:  1961-07       Impact factor: 3.982

Review 4.  Current concepts in prevention of prosthetic valve endocarditis.

Authors:  A S Bayer; R J Nelson; T G Slama
Journal:  Chest       Date:  1990-05       Impact factor: 9.410

Review 5.  Effect of cardiopulmonary bypass on the pharmacokinetics of drugs.

Authors:  F O Holley; K V Ponganis; D R Stanski
Journal:  Clin Pharmacokinet       Date:  1982 May-Jun       Impact factor: 6.447

6.  Vancomycin prophylaxis in cardiac operations: determination of an optimal dosage regimen.

Authors:  B F Farber; A W Karchmer; M J Buckley; R C Moellering
Journal:  J Thorac Cardiovasc Surg       Date:  1983-06       Impact factor: 5.209

7.  Bioactive antibiotic levels in the human aorta.

Authors:  D Mutch; G Richards; R A Brown; D S Mulder
Journal:  Surgery       Date:  1982-12       Impact factor: 3.982

8.  The effects and significance of subminimal inhibitory concentrations of antibiotics.

Authors:  J A Washington
Journal:  Rev Infect Dis       Date:  1979 Sep-Oct

9.  Loss of nitroglycerin to cardiopulmonary bypass apparatus.

Authors:  J F Dasta; J Jacobi; L S Wu; T Sokoloski; P Beckley; T E Reilley; M B Howie
Journal:  Crit Care Med       Date:  1983-01       Impact factor: 7.598

10.  Distribution of sodium cefazolin in serum, muscle, bone marrow, and bone of normal rabbits.

Authors:  D H Pitkin; C Sachs; I Zajac; P Actor
Journal:  Antimicrob Agents Chemother       Date:  1977-04       Impact factor: 5.191

View more
  8 in total

1.  Teicoplanin in cardiac surgery: intraoperative pharmacokinetics and concentrations in cardiac and mediastinal tissues.

Authors:  C Martin; P Bourget; M Alaya; A Sertin; C Atlani; K Ennabli; R Said
Journal:  Antimicrob Agents Chemother       Date:  1997-05       Impact factor: 5.191

Review 2.  Systemic antibiotic therapy for chronic osteomyelitis in adults.

Authors:  Brad Spellberg; Benjamin A Lipsky
Journal:  Clin Infect Dis       Date:  2011-12-12       Impact factor: 9.079

Review 3.  Penetration of antibacterials into bone: pharmacokinetic, pharmacodynamic and bioanalytical considerations.

Authors:  Cornelia B Landersdorfer; Jürgen B Bulitta; Martina Kinzig; Ulrike Holzgrabe; Fritz Sörgel
Journal:  Clin Pharmacokinet       Date:  2009       Impact factor: 6.447

4.  Penetration of ceftriaxone (1 or 2 grams intravenously) into mediastinal and cardiac tissues in humans.

Authors:  C Martin; X Viviand; M Alaya; F Lokiec; K Ennabli; R Said; M Pecking
Journal:  Antimicrob Agents Chemother       Date:  1996-03       Impact factor: 5.191

5.  Glycopeptide bone penetration in patients with septic pseudoarthrosis of the tibia.

Authors:  Silvia Garazzino; Alessandro Aprato; Lorena Baietto; Antonio D'Avolio; Agostino Maiello; Francesco Giuseppe De Rosa; Domenico Aloj; Marco Siccardi; Antonio Biasibetti; Alessandro Massè; Giovanni Di Perri
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

6.  Using a Vancomycin PBPK Model in Special Populations to Elucidate Case-Based Clinical PK Observations.

Authors:  Chie Emoto; Trevor N Johnson; Brooks T McPhail; Alexander A Vinks; Tsuyoshi Fukuda
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2018-02-15

7.  An antibiotic loaded ceramic sternum to treat destroyed infected sternum: 4 cases.

Authors:  Jeremy Tricard; Anaëlle Chermat; Souleiman El Balkhi; Eric Denes; François Bertin
Journal:  J Thorac Dis       Date:  2020-03       Impact factor: 2.895

8.  The combined application of antibiotic-loaded bone cement and vacuum sealing drainage for sternal reconstruction in the treatment of deep sternal wound infection.

Authors:  Xia Jiang; Yong Xu; Guoqing Jiao; Zhaohui Jing; Fanyu Bu; Jie Zhang; Liuyan Wei; Xiaosong Rong; Mingqiu Li
Journal:  J Cardiothorac Surg       Date:  2022-08-26       Impact factor: 1.522

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.